MeSH term
Frequency | Condition_Probility | Comparative Study | 10 | 0.0 |
Gene Expression Profiling | 4 | 0.0 |
Humans | 75 | 0.0 |
Oligonucleotide Array Sequence Analysis | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 50 | 0.0 |
Up-Regulation | 7 | 0.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Adult | 17 | 0.0 |
Aged | 14 | 0.0 |
Cluster Analysis | 2 | 1.0 |
Down-Regulation | 4 | 0.0 |
Female | 25 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Male | 20 | 0.0 |
Middle Aged | 14 | 0.0 |
Neoplasm Invasiveness/genetics | 2 | 4.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Animals | 21 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Mice | 9 | 0.0 |
Models, Molecular | 2 | 0.0 |
Rats | 6 | 0.0 |
Solubility | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Genotype | 3 | 0.0 |
Interstitial Collagenase/*genetics | 6 | 54.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Pregnancy | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Cell Division | 4 | 0.0 |
Cell Movement | 4 | 0.0 |
Cells, Cultured | 18 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Fibroblasts/*metabolism | 3 | 1.0 |
*Gene Expression Regulation | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Time Factors | 4 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Gene Frequency | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Interstitial Collagenase/genetics | 2 | 18.0 |
Odds Ratio | 2 | 0.0 |
Stromelysin 1/*genetics/metabolism | 2 | 50.0 |
3T3 Cells | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Blotting, Northern | 9 | 0.0 |
Blotting, Western | 6 | 0.0 |
Interstitial Collagenase/metabolism | 2 | 8.0 |
Neoplasm Invasiveness | 6 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Matrix Metalloproteinases/biosynthesis | 2 | 33.0 |
Tissue Inhibitor of Metalloproteinase-1/biosynthesis | 2 | 13.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/analysis | 2 | 22.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Stromelysin 1/*genetics | 2 | 11.0 |
Alleles | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/*blood | 2 | 25.0 |
Base Sequence | 7 | 0.0 |
Hydrolysis | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 4 | 0.0 |
Interstitial Collagenase/*analysis | 2 | 66.0 |
Matrix Metalloproteinases/metabolism | 3 | 6.0 |
Amino Acid Sequence | 6 | 0.0 |
Binding Sites | 5 | 0.0 |
Ligands | 2 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Protein Binding | 6 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Antigens, Nuclear/*physiology | 2 | 66.0 |
Autoantigens/*physiology | 2 | 33.0 |
Carrier Proteins/*physiology | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Nuclear Proteins/*physiology | 2 | 1.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Reference Values | 3 | 0.0 |
Collagenases/*metabolism | 3 | 10.0 |
Enzyme Activation | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/metabolism | 2 | 7.0 |
DNA, Complementary | 2 | 0.0 |
Collagen/physiology | 2 | 12.0 |
Gelatinase A | 4 | 5.0 |
Interstitial Collagenase | 12 | 28.0 |
Prognosis | 2 | 0.0 |
Metalloendopeptidases/*metabolism | 4 | 4.0 |
Rats, Wistar | 2 | 0.0 |
Chronic Disease | 2 | 0.0 |
Collagenases/metabolism | 2 | 5.0 |
Gelatinase B | 5 | 6.0 |
Chick Embryo | 2 | 0.0 |
Culture Media, Conditioned | 2 | 0.0 |
English Abstract | 4 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Fibroblasts/enzymology | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Umbilical Veins | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Retroviridae/genetics | 2 | 0.0 |
Extracellular Matrix/*enzymology | 2 | 15.0 |
*Down-Regulation | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Transcription Factor AP-1/*metabolism | 2 | 1.0 |
Kinetics | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Interleukin-1/metabolism | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Proteoglycans/metabolism | 2 | 2.0 |
Breast Neoplasms/*enzymology | 2 | 3.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Matrix Metalloproteinases/biosynthesis/genetics | 2 | 33.0 |
In Situ Hybridization | 2 | 0.0 |
Stromelysin 1 | 3 | 7.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
